📰 Michael Castagna News
Michael Castagna News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Castagna. Real-time updates on events, politics, business and more.
May 7, 2024
Clofazimine is an antibiotic that inhibits mycobacterial growth and binds preferentially to mycobacterial DNA.
April 3, 2024
Credit and security agreement with MidCap Financial Trust repaid in full for approximately $31.6 millionConvertible note issued to Mann Group LLC repaid in exchange for 1.5 million shares of common...
March 26, 2024
Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through Decem...
February 29, 2024
MannKind employees including CEO Michael Castagna, center, ring the opening bell of the Nasdaq on May 23. (courtesy photo) Westlake Village-based MannKind Corporation capped off a record year with a fourth quarter to remember, beating analysts' estimates and setting up for a brighter future. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary
February 29, 2024
MannKind Co. (NASDAQ:MNKD – Free Report) – Analysts at Wedbush issued their Q2 2024 earnings estimates for shares of MannKind in a research report issued to clients and investors on Wednesday, February 28th. Wedbush analyst A. Argyrides forecasts that the biopharmaceutical company will post earnings of $0.02 per share for the quarter. Wedbush currently has […]
February 29, 2024
MannKind Co. (NASDAQ:MNKD – Free Report) – Analysts at Leerink Partnrs decreased their Q3 2024 EPS estimates for shares of MannKind in a research note issued to investors on Wednesday, February 28th. Leerink Partnrs analyst T. Smith now anticipates that the biopharmaceutical company will post earnings per share of $0.02 for the quarter, down from […]
February 28, 2024
MNKD earnings call for the period ending December 31, 2023.
February 28, 2024
MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript February 27, 2024 MannKind Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to MannKind Corporation 2023 Fourth Quarter and Full Year Financial Results Earnings Call. As a […]
February 28, 2024
MannKind Co. (NASDAQ:MNKD – Get Free Report) shares rose 10.6% during trading on Wednesday . The company traded as high as $4.26 and last traded at $4.18. Approximately 1,060,401 shares traded hands during trading, a decline of 56% from the average daily volume of 2,431,067 shares. The stock had previously closed at $3.78. Wall Street […]
February 28, 2024
MannKind Co. (NASDAQ:MNKD – Get Free Report)’s share price rose 10.6% during trading on Wednesday . The company traded as high as $4.26 and last traded at $4.18. Approximately 1,060,401 shares were traded during trading, a decline of 56% from the average daily volume of 2,431,067 shares. The stock had previously closed at $3.78. Analyst […]